Veterinary Medicines

CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP

Authorised
  • Triclabendazole
  • Moxidectin
Download as PDF

Product identification

Medicine name:
CYDECTIN TRICLAMOX 1 MG/ML + 50 MG/ML ORAL SOLUTION FOR SHEEP
Cydectin triclamox 1 mg/ml + 50 mg/ml solução oral para ovinos
Active substance:
  • Triclabendazole
  • Moxidectin
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Triclabendazole
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Moxidectin
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        31
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • 1 L bottle
  • 5 L bottle
  • 2.5 L bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Portugal Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 206/01/09DFVPT
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0201/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 29/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."